The immune system: role in hypertension.

Area of Science:

• Immunology
• Cardiovascular Medicine
• Nephrology

Background:

• Low-grade inflammation is increasingly recognized as a factor in cardiovascular disease.
• Immune responses, involving both innate and adaptive immunity, contribute to inflammation in atherosclerosis and hypertension.
• Specific lymphocyte subsets and their cytokines play roles in vascular remodeling and hypertensive heart and kidney disease.

Purpose of the Study:

• To explore the involvement of immune mechanisms in the cardiac, vascular, and renal changes associated with hypertension.
• To investigate the roles of different T cell subsets (Th1, Th2, Th17, T regulatory cells) in mediating hypertensive effects.
• To identify potential triggers for immune activation in hypertension, such as neoantigens.

Main Methods:

• Review of experimental models of hypertension, including Dahl-salt sensitive and spontaneously hypertensive rats.
• Analysis of the roles of specific cytokines (e.g., interferon-γ, interleukin-4, interleukin-17) produced by T cell subsets.
• Examination of the influence of T regulatory cells expressing forkhead box P3.

Main Results:

• Effector T cells (Th1, Th2, Th17) and T regulatory cells exhibit pro- and anti-inflammatory effects, influencing angiotensin II and mineralocorticoid actions.
• Activated Th1 cells can elevate blood pressure by affecting the kidney, vascular remodeling, and perivascular fat.
• T regulatory cells demonstrate a protective role against blood pressure elevation.

Conclusions:

• Immune system activation, potentially triggered by neoantigens generated by elevated blood pressure, is implicated in hypertension.
• Specific T cell subsets mediate critical aspects of cardiovascular and renal pathology in hypertension.
• These findings suggest novel therapeutic strategies targeting immune pathways for improved hypertension and cardiovascular disease outcomes.